SARS-CoV-2 RT-qPCR Assay

Real-time PCR molecular diagnostic test for detection of SARS-CoV-2 virus. This assay enables rapid identification of COVID-19 infection through quantitative PCR methodology. The test was among the first developed and supplied in Korea.

Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.

Specialized real-time PCR diagnostic test for detection and identification of SARS-CoV-2 Omicron variant. This molecular assay enables variant-specific diagnostics for epidemiological monitoring and clinical management.

A rapid diagnostic test for detecting SARS-CoV-2 and future variants at the point of care. Plays a crucial role in infection control and prevention of viral spread.

Multiplex real-time PCR assay enabling simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B from a single sample. This molecular diagnostic test provides efficient multi-pathogen screening in clinical settings.

A multiplex real-time PCR assay for the VitaPCR™ platform that simultaneously detects Influenza and SARS-CoV-2 from patient samples.

Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.

Rapid molecular diagnostic assay for simultaneous detection of SARS-CoV-2, influenza, and RSV. Delivers real-time PCR results in 20 minutes from sample collection, enabling point-of-care testing and immediate clinical decision-making. Designed for deployment in clinical settings to reduce turnaround time and diagnostic costs.

Real-time PCR assay for qualitative detection of SARS-CoV-2 nucleic acid in respiratory samples. Provides rapid identification of COVID-19 infection for clinical diagnosis.

An RT-LAMP (Reverse Transcription Loop-mediated isothermal Amplification) assay for the detection of SARS-CoV-2 coronavirus using fluorometric detection with a DNA intercalating agent.

A PCR-based diagnostic test for the detection of SARS-CoV-2. This molecular assay is designed for accurate identification of COVID-19 infection in clinical samples.

RT-qPCR detection kit for SARS-CoV-2 identification in clinical samples. This CE-IVD marked assay enables rapid molecular diagnosis of COVID-19 through real-time quantitative PCR, suitable for laboratory and point-of-care testing environments. The kit provides sensitive and specific viral detection for respiratory samples.